David Dolling

Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial

Sheena McCormack, David Dunn, Monica Desai et al. · The Lancet · 2015 · 1.9K citations · Full text

Public Health, Pharmacotherapy, Preventive Medicine +14

Adjuvant chemotherapy in upper tract urothelial carcinoma (the POUT trial): a phase 3, open-label, randomised controlled trial

Alison Birtle, Mark Johnson, John Chester et al. · The Lancet · 2020 · 527 citations · Full text

Medicine, Oncology, Urology +15

Prostate-specific Membrane Antigen Heterogeneity and DNA Repair Defects in Prostate Cancer

Alec Paschalis, Beshara Sheehan, Ruth Riisnaes et al. · European Urology · 2019 · 465 citations · Full text

Medicine, Oncology, Urology +17

Circulating Cell-Free DNA to Guide Prostate Cancer Treatment with PARP Inhibition

Jane Goodall, Joaquı́n Mateo, Wei Yuan et al. · Cancer Discovery · 2017 · 422 citations · Full text

Life Sciences, Molecular Biology, Oncology +17

Androgen receptor splice variant-7 expression emerges with castration resistance in prostate cancer

Adam Sharp, Ilsa M. Coleman, Wei Yuan et al. · Journal of Clinical Investigation · 2018 · 393 citations · Full text

Medicine, Endocrinology, Oncology +17